Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

abbott biologicals b.v. veerweg 12 - a/guangdong-maonan/swl1536/2019 (h1n1)pdm09-like strain (a/guangdong-maonan/swl1536/2019, cnic-1909), a/hongkong/2671/2019 (h3n2)-like strain (a/hongkong/2671/2019, ivr-208), b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection - 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose

Canada - English - Health Canada

bgp pharma ulc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b 15mcg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - a/california/07/2009 (h1n1)v a/brisbane/59/2007 (h1n1) - like strain (a/brisbane/59/2007, ivr-148) ph.eur b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 15,15,15 microgram

Australia - English - Department of Health (Therapeutic Goods Administration)

mylan health pty ltd - influenza virus haemagglutinin -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

abbott laboratories s.a (pty) ltd., south africa - vaccine - suspension for injection - haemagglutinin of: • a/victoria/2570/2019 (h1n1) pdm09-like strain (a/victoria/2570/2019, ivr-215) 15 µg haemagglutinin • a/darwin/9/2021 (h3n2)-like strain (a/darwin/6/2021, ivr-227) 15 µg haemagglutinin • b/austria/1359417/2021-like strain (b/austr

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a/california/7/2009 (h1n1) - like strain 7.5ug (a/california/7/2009 nymc x-181); influenza virus a/hong kong/4801/2014 (h3n2) - like strain 7.5ug (a/new caledonia/71/2014, x-257a); influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008, wild type) - suspension for injection - 0.25 ml - active: influenza virus a/california/7/2009 (h1n1) - like strain 7.5ug (a/california/7/2009 nymc x-181) influenza virus a/hong kong/4801/2014 (h3n2) - like strain 7.5ug (a/new caledonia/71/2014, x-257a) influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza caused by the influenza virus, types a and b in children aged 6 months to 35 months.

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - a/california/7/2009 (h1n1)pdm09-like strain (a/california/7/2009, x-181) a/texas/50/2012 (h3n2)-like strain (a/texas/50/2012, x-223a) b/massachusetts/2/2012-like strain (b/massachusetts/2/2012, bx-51b) - suspension for injection - 15,15,15 microgram

Canada - English - Health Canada

bgp pharma ulc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b (victoria); haemagglutinin-strain b (yamagata) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b (victoria) 15mcg; haemagglutinin-strain b (yamagata) 15mcg - vaccines

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - inactivated influenza vaccine type a (a/new caledonia/20/99 ivr-116 (h1n1); inactivated influenza vaccine type b (b/shanghai/361/2002-like (b/jiangsu/10/2003); inactivated influenza vaccine type a (a/fujian/411/2002(h3n2)-like (a/wyoming/3/2003 x-147 reass) -